This project has received funding from the
Second European & Developing Countries
Clinical Trials Partnership Programme (EDCTP2)
under grant agreement No. RIA2019PD-2887
.
A pediatric phase I/II trial to determine safety and pharmacokinetics of broadly neutralizing monoclonal antibodies against HIV-1
This project has received funding from the
Second European & Developing Countries
Clinical Trials Partnership Programme (EDCTP2)
under grant agreement No. RIA2019PD-2887
.